first line treatment of egfr mutation-positive nsclc
Published 7 years ago • 115 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
7:11
the changing landscape of first line treatment for egfr mutation-positive nsclc.
-
7:59
dacomitinib beats iressa as first line treatment for egfr mutation-positive nsclc
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
6:31
gracecast - lcvl - what is the best first line treatment for patients with advanced egfr mutation-po
-
2:05
first line egfr based therapy for advanced squamous non small cell lung cancer nsclc
-
2:00
choosing first line therapy in egfr mutations
-
18:51
gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
-
17:45
individual treatments for individual egfr mutations
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
2:43
slcvl raez #14 current standards, leading options for first-line treatment of egfr mutation nsclc
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
4:09
egfr mutations: uncommon treatment & insurance complications -2022 program: targeted therapies forum
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md